Assessment of Potential Treatments to Treat Drug-induced Respiratory Depression and Overdose Toxicity
Award Notice Posted
- Solicitation number
- 75N95022D00019
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Lovelace Biomedical Research Institute
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N95022D00019 Federal IDV award
Notice details come from SAM.gov. Updated .
Notice text
NOTICE OF AWARD. THIS IS NOT A REQUEST FOR QUOTE/PROPOSALS.
On September 20, 2022; in response to the requirements of Solicitation 75N95022R00012, the National Institute on Drug Abuse (NIDA) awarded an Indefinite Delivery/Indefinite Quantity Contract No. 75N95022D00019 to Lovelace Biomedical Research Institute for the Assessment of Potential Treatments for Drug-induced Respiratory Depression and Overdose Toxicity. The ordering period for cost reimbursement plus fixed fee task orders will be from September 26, 2022 – September 25, 2027. The minimum order amount shall be $24,000 and the ceiling shall be $6,500,000 over the five-year ordering period.
Awarded contract 75N95022D00019 to Lovelace Biomedical Research Institute for 6500000.00 on 2022-09-20.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Assessment of Potential Treatments to Treat Drug-induced Respiratory Depression and Overdose Toxicity | Solicitation | |
| Assessment of Potential Treatments to Treat Drug-induced Respiratory Depression and Overdose Toxicity | Pre-Solicitation | |
| Assessment of Potential Treatments to Treat Drug-induced Respiratory Depression and Overdose Toxicity | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity